Live Breaking News & Updates on Determining Clinician Factors

Stay updated with breaking news from Determining clinician factors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Teva to Present Data for AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, AUSTEDO® (deutetra

Teva will share 16 data presentations across its neuroscience portfolio including AUSTEDO, once-daily AUSTEDO XR, UZEDY, TV-44749 (olanzapine) and AJOVY® (fremanezumab) injectionPresentation highlights include data for AUSTEDO in the tardive dyskinesia (TD) START study on real-world effectiveness and adherence when. ....

Eric Hughes , Yael Ashman , Sanjeev Sharma , Teva Pharmaceutical Industries Ltd , Drug Administration , Teva Pharmaceuticals , Psych Congress On , Week Patient Titration Kit , Risperidone Subcutaneous Extended Release Study , Maintenance Treatment , Determining Clinician Factors , Defeating Barriers , Teva Pharmaceutical Industries , Psych Congress , Executive Vice President , Chief Medical Officer , Clinician Factors , Tardive Dyskinesia , Treatment Patterns , Deutetrabenazine When Initiated Using , Interim Results , Real World Effectiveness , Population Estimate , Patients With Tardive Dyskinesia , Real World Clinical Practice , Real World Antipsychotic ,